Top Markets
#1 Zora Zora +28.88%
#2 Tutorial Tutorial +24.57%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +24.18%
#4 Arowana Arowana +23.56%
#5 Fabric Protocol Fabric Protocol +22.66%
#6 Pieverse Pieverse +22.10%
#7 EXOD EXOD +22.08%
#8 Backpack Backpack +22.06%
#9 The Black Bull The Black Bull +21.96%
#10 GALA GALA +21.77%
Coin of the day
Zora Zora
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Xspray Pharma AB (publ) Xspray Pharma AB (publ)

Xspray Pharma AB (publ)

XSPRAY
Clasificación en acciones #24889
Xspray Pharma AB (publ), a pharmaceutical firm based in Solna, Sweden,... Xspray Pharma AB (publ), a pharmaceutical firm based in Solna, Sweden, specializes in developing protein kinase inhibitors for precise cancer treatments. Their current drug pipeline includes HyNap-Nilo, aimed at chronic myeloid leukemia; HyNap-Sora, which targets renal, liver, and several types of thyroid cancer; and HyNap-Dasa, intended for both chronic myeloid leukemia and acute lymphoblastic leukemia. Established in 2003, the company was formerly known as Xspray Microparticles AB until its name change to Xspray Pharma AB (publ) in 2017.
Precio por acción
$1.18
Capitalización bursátil
$55.82M
Cambio (1 día)
1.35%
Cambio (1 año)
-73.35%
País
SE
Comercio Xspray Pharma AB (publ) (XSPRAY)

Categoría

Healthcare
Ganancias de Xspray Pharma AB (publ) (XSPRAY)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Xspray Pharma AB (publ), gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Xspray Pharma AB (publ) desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US